Alzheimer's disease (AD) is a major public health problem with substantial economic and
social impacts around the world. The hallmarks of AD pathogenesis include deposition of …

Alzheimer's disease (AD) is a devastating chronic neurodegenerative disease with currently
no available disease modifying treatment. In recent years, the peptide amyloid-β has been …

Alzheimer's disease (AD) is characterized by three major histopathological hallmarks: β-
amyloid deposits, neurofibrillary tangles and gliosis. While neglected for decades, the …

Introduction: Despite the revolutionary progress in neurodegenerative disease research,
there is no cure for Alzheimer's disease (AD). This is a chronic progressive …

Alzheimer's disease (AD) is a progressive dementing neurologic illness, and the most
frequent cause of dementia in the elderly. Neuritic plaques are one of the main …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder of the brain, which is
characterized by the formation of extracellular amyloid plaques (or senile plaques) and …

Alzheimer's disease (AD) is characterized by amyloid beta (Aβ) accumulation, tau pathology
and neuroinflammation. Recently, there has been considerable interest in the role of …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder affecting elderly
people worldwide, which is mainly characterized by cerebral amyloid-beta (Aβ) plaque …

Neuroinflammation is now regarded as both an early event and prime mover in the
pathobiology of Alzheimer disease (AD), a neurodegenerative disease that represents a …

Neuroinflammation is considered one of the cardinal features of Alzheimer's disease (AD).
Neuritic plaques composed of amyloid β and neurofibrillary tangle-laden neurons are …